0001161697-24-000194.txt : 20240410 0001161697-24-000194.hdr.sgml : 20240410 20240410171534 ACCESSION NUMBER: 0001161697-24-000194 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240408 FILED AS OF DATE: 20240410 DATE AS OF CHANGE: 20240410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tierney David S CENTRAL INDEX KEY: 0001292636 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 24836580 MAIL ADDRESS: STREET 1: C/O ABLE LABORATORIES, INC. STREET 2: 6 HOLLYWOOD COURT, CN 1013 CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 04-08-2024 X0508 4 2024-04-08 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001292636 Tierney David S 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 1 0 0 0 0 Common stock, par value $0.001 per share 2024-04-08 4 M 0 25000 4.01 A 373874 D Common stock, par value $0.001 per share 2024-04-08 4 S 0 25000 15.68 D 348874 D Options to purchase common stock 4.01 2024-04-08 4 M 0 25000 0 A 2025-01-02 Common Stock 25000 203931 D Shares were sold on the open market to fund payment of a personal tax liability and not as a result of any disagreement with the Company. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.55 to $15.77 per share. Options vested in three annual tranches beginning on January 2, 2019. /s/ David S. Tierney 2024-04-10